đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of the study is to compare the immunogenicity and safety of a b...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-04-01
Trial ID
NCT01245049
Treatments Being Tested
This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT01457508
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03-24
Trial ID
NCT00196976
The aim of this study is to assess antibody persistence in infants who rece...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-05-30
Trial ID
NCT01358825
Treatments Being Tested
The purpose of this study is to assess the safety in terms of fever (rectal...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-25
Trial ID
NCT00463437
The goal of this observational study is to learn about vaccine immunity in ...
Status
Recruiting
Location
University Hospital Bern
Start Date
2023-11-14
Trial ID
NCT06333275
The purpose of this study is to evaluate the safety, reactogenicity, and im...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2024-01-15
Trial ID
NCT06213506
This study aims to evaluate the safety, reactogenicity and immunogenicity o...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10-01
Trial ID
NCT00390910
Treatments Being Tested
This study will evaluate the persistence of immunity to hepatitis B 10 to 1...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-07
Trial ID
NCT01138098
Treatments Being Tested
This study will evaluate GSK Biologicals' DTPa-HBV-IPV/Hib vaccine given as...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-23
Trial ID
NCT00753649
Treatments Being Tested